These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

949 related items for PubMed ID: 29402873

  • 1. Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features.
    Hatz K, Ebneter A, Tuerksever C, Pruente C, Zinkernagel M.
    Ophthalmologica; 2018; 239(4):205-214. PubMed ID: 29402873
    [Abstract] [Full Text] [Related]

  • 2. Morphological and functional changes in recalcitrant diabetic macular oedema after intravitreal dexamethasone implant.
    Iacono P, Parodi MB, Scaramuzzi M, Bandello F.
    Br J Ophthalmol; 2017 Jun; 101(6):791-795. PubMed ID: 27625164
    [Abstract] [Full Text] [Related]

  • 3. Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema.
    Vujosevic S, Torresin T, Bini S, Convento E, Pilotto E, Parrozzani R, Midena E.
    Acta Ophthalmol; 2017 Aug; 95(5):464-471. PubMed ID: 27775223
    [Abstract] [Full Text] [Related]

  • 4. Dexamethasone for unresponsive diabetic macular oedema: optical coherence tomography biomarkers.
    Bonfiglio V, Reibaldi M, Pizzo A, Russo A, Macchi I, Faro G, Avitabile T, Longo A.
    Acta Ophthalmol; 2019 Jun; 97(4):e540-e544. PubMed ID: 30318792
    [Abstract] [Full Text] [Related]

  • 5. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
    Callanan DG, Loewenstein A, Patel SS, Massin P, Corcóstegui B, Li XY, Jiao J, Hashad Y, Whitcup SM.
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
    [Abstract] [Full Text] [Related]

  • 6. OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.
    Zur D, Iglicki M, Busch C, Invernizzi A, Mariussi M, Loewenstein A, International Retina Group.
    Ophthalmology; 2018 Feb; 125(2):267-275. PubMed ID: 28935399
    [Abstract] [Full Text] [Related]

  • 7. Early response to ranibizumab predictive of functional outcome after dexamethasone for unresponsive diabetic macular oedema.
    Cicinelli MV, Cavalleri M, Querques L, Rabiolo A, Bandello F, Querques G.
    Br J Ophthalmol; 2017 Dec; 101(12):1689-1693. PubMed ID: 28432109
    [Abstract] [Full Text] [Related]

  • 8. Correlation between Deep Capillary Plexus Perfusion and Long-Term Photoreceptor Recovery after Diabetic Macular Edema Treatment.
    Moon BG, Um T, Lee J, Yoon YH.
    Ophthalmol Retina; 2018 Mar; 2(3):235-243. PubMed ID: 31047592
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dexamethasone Intravitreal Implant for Chronic Diabetic Macular Edema Resistant to Intravitreal Bevacizumab Treatment.
    Totan Y, Güler E, Gürağaç FB.
    Curr Eye Res; 2016 Mar; 41(1):107-13. PubMed ID: 25610946
    [Abstract] [Full Text] [Related]

  • 14. MEASUREMENTS OF RETINAL FLUID BY OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN DIABETIC MACULAR EDEMA: A Biomarker of Visual Acuity Response to Treatment.
    Santos AR, Alves D, Santos T, Figueira J, Silva R, Cunha-Vaz JG.
    Retina; 2019 Jan; 39(1):52-60. PubMed ID: 29077605
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Baseline SD-OCT characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants.
    Eandi CM, De Geronimo D, Giannini D, Polito MS, Tosi GM, Neri G, Le Mer Y, Varano M, Parravano M.
    Acta Diabetol; 2020 Jul; 57(7):867-874. PubMed ID: 32114643
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dril Influences Short-term Visual Outcome after Intravitreal Corticosteroid Injection for Refractory Diabetic Macular Edema.
    Luís ME, Sampaio F, Costa J, Cabral D, Teixeira C, Ferreira JT.
    Curr Eye Res; 2021 Sep; 46(9):1378-1386. PubMed ID: 33463388
    [Abstract] [Full Text] [Related]

  • 20. The Interval between Treatments of Bevacizumab and Dexamethasone Implants for Diabetic Macular Edema Increased over Time in the BEVORDEX Trial.
    Mehta H, Fraser-Bell S, Nguyen V, Lim LL, Gillies MC.
    Ophthalmol Retina; 2018 Mar; 2(3):231-234. PubMed ID: 31047591
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.